Aims-To study correlations between the pattern of silver stained nucleolar organiser regions (AgNORs) in chronic lymphocytic leukaemia (CLL) and parameters of tumour kinetics. To investigate whether quantitation of the AgNOR pattern can be used to discriminate between patients with stable and progressive disease. Methods-Peripheral blood smears from 48 patients with CLL, classified as having either stable or progressive disease (Rai stage III or IV; bulky lymph nodes or massive splenomegaly; or peripheral lymphocytes >100 x 10911), were studied. For each patient, total tumour mass (TTM) and for patients undergoing a period of observation without treatment, the TTM duplication time (DT) and the lymphocyte doubling time (LDT) were calculated. 
Silver staining of nucleolar organiser regions (AgNORs) in interphase cells has been used to evaluate cell proliferation in many tumour types.'-10 Quantification of AgNORs has a predictive value in several neoplasias, such as nonHodgkin's lymphoma,2 breast carcinoma,'4 neuroblastoma,l and multiple myeloma.9 The AgNOR pattern can be regarded as a parameter of cell kinetics in normal haemopoiesis,6 acute leukaemia8 " and chronic myeloid leukaemia.'2 The few studies on AgNORs in chronic lymphocytic leukaemia (CLL) " ' have described the morphology of the method but did not investigate the physiological significance of AgNORs as a parameter of cell kinetics.
CLL is a lymphoproliferative disease of mainly quiescent lymphocytes in Go phase. '4 15 In patients with stable disease there is a small tumour mass at diagnosis and the disease runs a relatively stable course, sometimes for years. Under these conditions, treatment is not necessary. [15] [16] [17] [18] The TTM was calculated as described by Jaksic and Vitale,24 using the following formula: TTM = (L)05 + LN + S where L is the peripheral lymphocyte count, LN is the diameter of the largest palpable lymph node in cm and S is size of the spleen below the left costal margin in cm.
For patients followed for at least three months, the TTM doubling time was calculated according to the formula:
where TTM1 is the TTM at the beginning and TTM2 the TTM at the end of the observation period. M is the period of observation in months.
The LDT was calculated using the best fit equation for simple regression on WinSTAT (version 3.1) software (Kalmia Inc., Cambridge, MA, USA) between the variables "date" and "lymphocyte count". This parameter was calculated only when four or more peripheral cell blood counts were available over a treatment-free period of at least three months. (table 3) .
As shown in table 4, age correlated significantly with TTM. When the variable percentage of cells with clusters was constant, there was a strong negative correlation between age and DT (r = -0.88), but not between age and TTM.
Linear discriminant analysis of the percentages of cells with the different AgNOR patterns as independent variables and the categories stable or progressive disease as the dependent ones gave the following standardised coefficients: 1.51 for cells with clusters; 0.04 for cells with a single compact nucleolus; -0.01 for cells with two compact nucleoli; and 0.22 for cells with scattered silver stained dots. The Mahalanobis distance was 2.59 (p < 0.0001).
Jackknive analysis correctly classified 45 (94%) of the 48 patients. Because the standardised coefficients showed clearly that the percentage of clusters was the most important factor for discriminating between patients with stable and progressive disease, we did another discriminant analysis with this parameter as the only independent variable. The jackknive procedure again classified 45 (94%) patients correctly. In the three cases which had been placed in the wrong category, 13% of cells contained clusters. 
